Global Bacterial Conjunctivitis Drugs Market 2016-2020

Table of Content

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Overview: Bacterial conjunctivitis

• Conjunctivitis
• Bacterial conjunctivitis
• Signs and symptoms
• Diagnosis
• Management
• Economic burden

PART 06: Pipeline analysis

• FST-100
• AzaSite Xtra (ISV-405)

PART 07: Antimicrobial resistance

• Initiatives to improve innovation of antibiotics

PART 08: Legislation relating to antibiotic use in US

PART 09: Market landscape

• Market overview
• Market size and forecast
• Bacterial conjunctivitis drugs market in US
• Five forces analysis

PART 10: Market segmentation by drug class

• Fluoroquinolones
• Aminoglycosides
• Macrolides
• Other

PART 11: Geographical segmentation

• Global bacterial conjunctivitis drugs market by geography 2015-2020
• Bacterial conjunctivitis drugs market in Americas
• Bacterial conjunctivitis drugs market in EMEA
• Bacterial conjunctivitis drugs market in APAC

PART 12: Market drivers

• Rising awareness about infection
• Development of multidrug-resistant variants
• Prevalence of bacterial conjunctivitis

PART 13: Impact of drivers

PART 14: Market challenges

• Patent expiry of drugs
• Contentment with existing therapies
• Adverse effects and limited efficacy of drugs
• Weak R&D of drugs

PART 15: Impact of drivers and challenges

PART 16: Market trends

• Strategic alliances and M&A
• Use of combination therapies
• Patient assistance programs

PART 17: Vendor landscape

• Competitive scenario
• Akorn
• Alcon
• Allergan
• Bausch & Lomb
• Other prominent vendors

PART 18: Appendix

• List of abbreviations

PART 19: Explore Technavio